Key result
Long-term antithrombotic regimens for patients with atrial fibrillation and stable coronary artery disease will be evaluated for efficacy and safety in this Cochrane Review protocol.
Why the study?
To assess the efficacy and safety of different long-term antithrombotic regimens for people with AF and stable CAD.
Do different long-term antithrombotic regimens improve efficacy and safety in people with atrial fibrillation and stable coronary artery disease?
Do different long-term antithrombotic regimens improve efficacy and safety in people with atrial fibrillation and stable coronary artery disease?
Answers are grounded in this paper and cite their sources.
Protocol for Cochrane review on antithrombotic regimens in AF with stable CAD; leaves optimal long-term strategy open pending evidence synthesis.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the efficacy and safety of different long‐term antithrombotic regimens for people with AF and stable CAD.
No takes yet. Share an insight, caveat, or question.
Zhan et al. (2021) studied this question. Long-term antithrombotic regimens for patients with atrial fibrillation and stable coronary artery disease will be evaluated for efficacy and safety in this Cochrane Review protocol.
Synapse has enriched 10 related papers. Consider them for comparative context: